Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01852032 · ClinicalTrials.gov registry record · NA
Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT01852032 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 23 participants.
The verdict
NCT01852032, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the imaging performance of an investigational breast computed tomography (CT) scanner, built at UC Davis, with that of an FDA-Approved breast tomosynthesis scanner (capable of producing standard 2-D mammography and 3-D tomosynthesis images), built by Hologic, Incorporated, in a group of patients with suspected breast cancer.
Interventions
- RADIATION Tomosynthesis Breast Scanning
- RADIATION Breast CT Scanning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2010-11 |
| Est. Completion | 2016-03-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01852032
The ClinicalTrials.gov registry entry for NCT01852032 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tomosynthesis Breast Scanning is the first listed.
NCT01852032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01852032 about?
NCT01852032 is a clinical study titled "Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis". The purpose of this study is to compare the imaging performance of an investigational breast computed tomography (CT) scanner, built at UC Davis, with that of an FDA-Approved breast tomosynthesis scanner (capable of producing standard 2-D mammography and 3-D tomosynthesis images), built by Hologic, ...
What is the current status of trial NCT01852032?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2010-11. Estimated completion is 2016-03-04.
What interventions are being tested in trial NCT01852032?
The interventions under investigation include: Tomosynthesis Breast Scanning (RADIATION), Breast CT Scanning (RADIATION).
Who is sponsoring clinical trial NCT01852032?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.